At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LNAI Lunai Bioworks
Trading 10-23 09:33:17 EDT
0.2835
-0.1865
-39.68%
High0.2950Low0.2600Vol199.67K
Open0.2600D1 Closing0.4700Amplitude7.45%
Mkt Cap1.43MTradable Cap878.76KTotal Shares5.03M
T/O55.00KT/O Rate6.44%Tradable Shares3.10M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Lunai Bioworks Expects NASDAQ Trading Suspension on October 30
Reuters  ·  07:00
Lunai Bioworks Expects NASDAQ Trading Suspension on October 30
Lunai Bioworks Announces Receipt of NASDAQ Determination and Intention to Voluntarily Delist and Deregister
THOMSON REUTERS  ·  07:00
Lunai Bioworks Announces Receipt of NASDAQ Determination and Intention to Voluntarily Delist and Deregister
NASDAQ Trade Halt Volatility Trading Pause at 02:06 Pm
Reuters  ·  10-10
NASDAQ Trade Halt Volatility Trading Pause at 02:06 Pm
Lunai Bioworks Alleges Abusive Short Selling in Lawsuit Against Seven Points Capital, Others
Reuters  ·  10-10
Lunai Bioworks Alleges Abusive Short Selling in Lawsuit Against Seven Points Capital, Others
Stock Market: Will S&P 500 Open Up or Down Today?
Benzinga Earnings  ·  10-02
Stock Market: Will S&P 500 Open Up or Down Today?
Top News Today: Stocks Rise After Bond Market Flips in Choppy Trading
Dow Jones  ·  10-02
Top News Today: Stocks Rise After Bond Market Flips in Choppy Trading
Lunai Bioworks Inc: Files for Non Timely 10-K with U.S. SEC
THOMSON REUTERS  ·  09-30
Lunai Bioworks Inc: Files for Non Timely 10-K with U.S. SEC
Lunai Bioworks Inc: Anticipates Reporting a Net Loss for the Fiscal Year Ended June 30, 2026 of About $3.2 Million
THOMSON REUTERS  ·  09-30
Lunai Bioworks Inc: Anticipates Reporting a Net Loss for the Fiscal Year Ended June 30, 2026 of About $3.2 Million
Lunai Bioworks Delays Annual Report Filing After Missing Form 10-K Deadline
Reuters  ·  09-30
Lunai Bioworks Delays Annual Report Filing After Missing Form 10-K Deadline
Lunai Bioworks Signs Exclusive Parkinson’s Cellular Phenotyping Deal with Tanaist
Reuters  ·  09-22
Lunai Bioworks Signs Exclusive Parkinson’s Cellular Phenotyping Deal with Tanaist
Lunai Bioworks - to Own Collaboration-Generated Results and Intellectual Property
THOMSON REUTERS  ·  09-22
Lunai Bioworks - to Own Collaboration-Generated Results and Intellectual Property
Lunai Bioworks - Receives Exclusive Rights to Tanaist Cellular Phenotyping Technology for Parkinson's
THOMSON REUTERS  ·  09-22
Lunai Bioworks - Receives Exclusive Rights to Tanaist Cellular Phenotyping Technology for Parkinson's
Lunai Bioworks (Nasdaq: Lnai) Expands Parkinson's Platform Through Exclusive Tanaist Agreement
THOMSON REUTERS  ·  09-22
Lunai Bioworks (Nasdaq: Lnai) Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Lunai Bioworks Reports 0.88 AUROC in Structure-Based AChE Inhibitor Screening Model Using NIH Tox21 Data
Reuters  ·  09-16
Lunai Bioworks Reports 0.88 AUROC in Structure-Based AChE Inhibitor Screening Model Using NIH Tox21 Data
Lunai Bioworks Corrects Link to Second Amended Complaint in Naked Short Selling Suit Release
Reuters  ·  09-04
Lunai Bioworks Corrects Link to Second Amended Complaint in Naked Short Selling Suit Release
Lunai Bioworks - Second Amended Complaint Alleges Securities Fraud and Market Manipulation Under Rule 10B-5
THOMSON REUTERS  ·  08-27
Lunai Bioworks - Second Amended Complaint Alleges Securities Fraud and Market Manipulation Under Rule 10B-5
Lunai Bioworks - Files Second Amended Complaint Naming Six Broker-Dealers and Two Principals
THOMSON REUTERS  ·  08-27
Lunai Bioworks - Files Second Amended Complaint Naming Six Broker-Dealers and Two Principals
Lunai Bioworks Lawsuit Names Six Broker-Dealers in Alleged Naked Short Selling Scheme
Reuters  ·  08-27
Lunai Bioworks Lawsuit Names Six Broker-Dealers in Alleged Naked Short Selling Scheme
Lunai Bioworks Signs Collaboration Agreement with BrainStorm Therapeutics on Parkinson’s Disease Research
Reuters  ·  08-05
Lunai Bioworks Signs Collaboration Agreement with BrainStorm Therapeutics on Parkinson’s Disease Research
Lunai Bioworks - Initial Parkinson's Disease Data Readout Targeted for First Half of 2027
THOMSON REUTERS  ·  08-05
Lunai Bioworks - Initial Parkinson's Disease Data Readout Targeted for First Half of 2027

Introduction

Company Name.
Lunai Bioworks
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--